BIRAC PACE Eligibility Documents Checklist 2026: Apply Now

Navigating the BIRAC PACE Scheme for Academic and Industrial Translation

Translating world-class scientific discoveries from university laboratories into viable commercial biotechnology products has historically been hindered by a critical funding gap. To address this structural bottleneck, the Biotechnology Industry Research Assistance Council (BIRAC), under the Department of Biotechnology (DBT), Government of India, formulated the Promoting Academic Research Conversion to Enterprise (PACE) scheme. Designed to bridge the chasm between academic innovation and industrial commercialization, PACE offers robust financial support and strategic frameworks for researchers and enterprises looking to scale up breakthrough technologies.

Whether you are an academic researcher preparing a proof-of-concept or an industrial entity entering into a co-development partnership, navigating the application workflow requires strict adherence to regulatory guidelines. This comprehensive guide outlines the precise BIRAC PACE eligibility documents checklist, structural pathways, key compliance frameworks, and actionable strategies to position your application for success on the first submission.

Understanding the Dual Tracks: AIR and CRS

The PACE scheme operates through two distinct operational mechanisms, each tailored to specific collaborative and developmental frameworks. Understanding which track aligns with your institutional structure is the first step toward securing non-dilutive capital.

1. Academic Innovation Research (AIR) Track

The AIR track is specifically engineered for academic researchers, university faculty, and scientists operating within recognized public or private Indian academic institutions. It provides up to ₹50 Lakh as a 100% grant-in-aid to support translational research activities. The primary focus of the AIR track is to help academic labs establish robust proof-of-concept, validate early-stage technologies, and generate preliminary industrial-scale data.

2. Contract Research Scheme (CRS) Track

The CRS track fosters collaborative synergy by funding joint translational projects between an academic institute and an industrial partner. Offering up to ₹50 Lakh in funding, this mechanism enables registered Indian companies to contract specialized academic expertise to solve complex biopharmaceutical, diagnostic, or agribiotech challenges. The industrial partner acts as the commercialization vehicle, driving the technology closer to market deployment.

Section 1: Who May Qualify (Eligibility Criteria)

Securing approval from BIRAC's apex Technical Screening Committees requires meeting stringent eligibility benchmarks. Submitting an application without satisfying these baseline criteria leads to immediate administrative rejection. Review the following qualifying standards carefully:

• Academic Standing (AIR): Applicants must hold regular faculty or permanent research positions in recognized Indian academic institutes, state/central universities, or national research laboratories.
• Collaborative Framework (CRS): Proposals must involve a formal partnership between an eligible Indian academic institution and an Indian-registered industrial company.
• Industrial Shareholding Compliance: The industrial partner participating in the CRS track must be legally incorporated in India and maintain at least 51% Indian shareholding.
• Preliminary Scientific Data: Applicants must possess documented preliminary laboratory data, prototype models, or in-vitro/in-vivo results demonstrating clear scientific feasibility.
• Target Domain Alignment: The proposed technology must focus on commercial translation within high-impact sectors, including biopharmaceuticals, molecular diagnostics, agricultural biotechnology, medical devices, or industrial bio-processes.
• Institutional Endorsement: The project submission must be officially endorsed, vetted, and signed off by the Executive Head (Vice-Chancellor, Director, or Registrar) of the Academic Institution and the Board of Directors of the partnering company.

Section 2: Potential Benefits Breakdown

The PACE scheme delivers substantial financial, structural, and strategic incentives designed to accelerate biotech innovation in India. Key advantages include:

• Non-Dilutive Capital Injection: Access up to ₹50 Lakhs in non-dilutive grant funding, allowing founders and researchers to retain absolute equity ownership of their intellectual property and upcoming ventures.
• Comprehensive Expense Coverage: Funding extends directly to crucial translational activities, including process optimization, scale-up synthesis, formulation development, toxicology studies, and preclinical validation using certified animal models.
• Consumables and Manpower Support: Grants cover specialized reagents, laboratory consumables, and the salaries of project scientists, Junior Research Fellows (JRFs), and Senior Research Fellows (SRFs).
• IP Protection and Retention: Participating academic institutions retain primary patent ownership, with structured commercial licensing frameworks established for industrial partners.
• Spin-Off Incubation Support: Successful projects receive comprehensive guidance on spinning off academic research into independent private venture startups, complete with business model validation.
• Overhead and Institutional Credit: Designated overhead funds are credited directly to host university departments to upgrade laboratory infrastructure and research capabilities.

To evaluate how these benefits apply to your specific institutional roadmap, review the detailed guidelines and submission portals on our dedicated BIRAC PACE scheme overview page.

Section 3: Key Documentation Requirements (Compliance Checklist)

A successful application relies heavily on comprehensive, accurate, and professionally formatted documentation. Incomplete submissions or missing compliance certificates are the leading cause of rejection during the administrative screening phase. Ensure your proposal package includes every item from the following checklist:

• Complete Project Proposal: Drafted strictly in the official BIRAC PACE format, detailing technical background, scientific novelty, detailed methodology, and quarter-by-quarter milestones.
• Itemized Budget Breakdown: Detailed financial estimates with verifiable vendor quotations for specialized reagents, testing charges, equipment utilization, and animal model procurement.
• Institutional Endorsement Letter: Signed official endorsement letter from the Head of the Academic Institution (VC/Director) confirming space, infrastructure, and administrative support.
• Collaborative MoU / Agreement: Executed Memorandum of Understanding or legal co-development agreement between the academic partner and the industrial company (mandatory for CRS proposals).
• Corporate Incorporation Proof: Company Incorporation Certificate, Memorandum of Association (MoA), Articles of Association (AoA), and verified Indian Shareholding Pattern certificate (for industrial partners).
• Regulatory Clearances: Mandatory Institutional Biosafety Committee (IBSC) approval and Institutional Animal Ethics Committee (IAEC) clearance certificates, where applicable.
• Banking Verification: Official bank account details, cancelled cheque, and PFMS (Public Financial Management System) registration documents of the host academic institution.

Section 4: Common Application Mistakes to Avoid

Even highly innovative biotechnology projects fail to secure funding due to avoidable procedural errors. To maximize your chances of clearing technical and financial vetting, steer clear of these frequent pitfalls:

• Vague Milestone Planning: Submitting generalized research goals instead of measurable, time-bound, and quantitative milestones (e.g., failing to specify exact yield targets, purity percentages, or testing timelines).
• Underestimating Regulatory Requirements: Delaying applications for IBSC or IAEC clearances. These regulatory certificates must be initiated concurrently with proposal drafting; lacking them at the review stage results in immediate disqualification.
• Unrealistic Budget Projections: Inflating equipment budgets while underfunding consumables and manpower, or failing to provide competitive vendor quotations for specialized reagents.
• Overlooking IP and Ownership Clauses: Submitting joint proposals under the CRS track without a clearly defined intellectual property licensing agreement between the university and the corporate partner.
• Ignoring Shareholding Compliance: Failing to verify that the industrial partner in a CRS application meets the strict threshold of 51% or greater Indian shareholding.

Strategic Action Plan for 2026 Applicants

Securing a BIRAC PACE grant requires meticulous preparation, scientific rigor, and strict regulatory compliance. Begin by aligning your core research team with an appropriate industrial or academic partner depending on your chosen track (AIR or CRS). Ensure your preliminary laboratory data is comprehensively documented and that all institutional ethics and biosafety clearances are secured well in advance of the submission window.

By preparing a robust project proposal supported by verified financial estimates and transparent IP agreements, your organization can successfully unlock up to ₹50 Lakhs in non-dilutive government capital to commercialize breakthrough biotechnology innovations.